OpenNeedle Ask your own

Question explored with the scientific record

Answered on this page ↓

what us the IIEF-5

Sep 19, 2026 · 4 sources used · OpenNeedle synthesis
The IIEF-5 is a 5-question screening tool that measures erectile dysfunction severity, scored from 5 (severe) to 25 (normal).

The International Index of Erectile Function-5 (IIEF-5) was developed and validated in a 1999 study of 1,152 men, 1,036 of whom had ED [2]. In that study, the average IIEF-5 score among men with ED was 11.1, compared to 23.3 in controls. The tool had 98% sensitivity and 88% specificity at a cutoff score of 21 or below [2].

The five questions cover confidence in getting an erection, ability to penetrate, ability to maintain an erection during intercourse, difficulty maintaining an erection to completion, and overall satisfaction. Scores are categorical: 22-25 is normal, 17-21 mild ED, 12-16 mild-to-moderate, 8-11 moderate, and 5-7 severe [2]. A weighted kappa of 0.82 indicates good agreement of the 5-item version with the full 15-item IIEF diagnostic domain [2].

CategoryScore rangeInterpretation
Normal22-25No ED
Mild17-21Mild ED
Mild-Moderate12-16Mild-moderate ED
Moderate8-11Moderate ED
Severe5-7Severe ED

A 2012 reliability study found that total IIEF scores did not differ significantly between two administrations 1-3 days apart (17.2 vs 17.1, p=0.20), but no patient answered identically on both questionnaires [3]. Answers shifted by only one response option for most patients who changed, so the tool is reliable for tracking big shifts but may miss small changes from a single measurement [3].

The IIEF-5 is also used as a study outcome. In the varicocelectomy study, it captured the shift from severe/moderate ED toward mild/absent ED after surgery [1]. In the CP/CPPS study, 39.9% of 839 men (326) had ED measured by IIEF-5, but ED did not correlate with UPOINT subtype number or NIH-CPSI score [4].

My call: The IIEF-5 is a well-validated, quick screening tool for ED severity that you can complete in about 2 minutes. Score below 21 signals ED. Track changes weekly to see real progress.

Confidence: high. The tool's diagnostic performance was established in a large validation cohort with clear cutoff scores and strong sensitivity/specificity [2].

Keep digging

Sources used 4

  1. Evaluation of the Erectile Dysfunction and Comparison of Serum Testosterone Level Before and After Varicocelectomy in Patients with Varicocele Referred to Sina Hospital Journal of Research in Urology (2022) primary study Strong

    In a single-arm before-after study of 115 men with varicocele at Sina Hospital (Tehran, 2018-2019), varicocelectomy was followed by a significant mean serum total testosterone increase of about 124 ng/dL (23.6±7.8%) and significant improvement in erectile dysfunction three month…

    DOI: 10.32592/jru.5.2.42
  2. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction International Journal of Impotence Research (1999) Thin

    This study developed and evaluated a 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction, demonstrating its high sensitivity and specificity in identifying the presence and severity of the condition.

    DOI: 10.1038/sj.ijir.3900472
  3. Despite Some Comprehension Problems the International Index of Erectile Function Is a Reliable Questionnaire in Erectile Dysfunction primary study Strong

    The physician-assisted IIEF showed no statistically significant difference between first and second total scores (17.2 vs 17.1, p=0.20) and internal consistency (Cronbach's alpha 1 0.9); item answers varied, with changes often adjacent.

    DOI: 10.1159/000335432
  4. Use of the UPOINT Classification in Turkish Chronic Prostatitis or Chronic Pelvic Pain Syndrome Patients Urology (2016) Thin

    A large Turkish retrospective study of 839 male CP/CPPS patients assessing the distribution of UPOINT domains and their relationship to NIH-CPSI scores and erectile dysfunction, finding a strong link between UPOINT domains and NIH-CPSI overall but no meaningful contribution of i…

    DOI: 10.1016/j.urology.2016.07.023

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question